You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 135 No. 2, February 1981 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  ARTICLES
 •Online Features
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (28)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Hyperthyroidism in Children

A Reevaluation of Treatment

Bruce A. Buckingham, MD; Gertrude Costin, MD; Thomas F. Roe, MD; Jordan J. Weitzman, MD; Maurice D. Kogut, MD

Am J Dis Child. 1981;135(2):112-117.


Abstract



• The results of medical and surgical therapy were determined in 107 hyperthyroid children. After surgery, 85% of patients were rendered free of hyperthyroidism; however, 62% became hypothyroid. After medical treatment, 30% of patients were euthyroid and 2% became hypothyroid. The relapse rate, however, was higher after medical (22%) than after surgical (9%) therapy. Serious drug-related complications (arthritis-, hepatitis-, and collagen disease-like syndromes) occurred in 14% of patients. Complications occurred in 9% of surgically treated patients, but recurrent laryngeal nerve injury or permanent hypoparathyroidism did not occur. In medically treated patients, both a goiter size less than three times normal prior to treatment and a reduction in goiter size to less than two times normal at the completion of therapy correlated with a successful outcome.

(Am J Dis Child 1981;135:112-117)



Author Affiliations



From the Division of Endocrinology and Metabolism, Department of Pediatrics (Drs Buckingham, Costin, Roe, and Kogut), and the Division of Pediatric Surgery, Department of Surgery (Dr Weitzman), Childrens Hospital of Los Angeles; and the University of Southern California School of Medicine, Los Angeles.


Footnotes



Reprint requests to Childrens Hospital of Orange County, 1109 W La Veta Ave, Orange, CA 92668 (Dr Buckingham).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Predicting the Likelihood of Remission in Children With Graves' Disease: A Prospective, Multicenter Study
Glaser et al.
Pediatrics 2008;121:e481-e488.
ABSTRACT | FULL TEXT  

Fifty Years of Experience with Propylthiouracil-Associated Hepatotoxicity: What Have We Learned?
Williams et al.
J. Clin. Endocrinol. Metab. 1997;82:1727-1733.
ABSTRACT | FULL TEXT  

Relapse Markers in Childhood Thyrotoxicosis
Tan et al.
CLIN PEDIATR 1987;26:136-139.
ABSTRACT  

Cardiac Complications in Juvenile Hyperthyroidism
Cavallo et al.
Arch Pediatr Adolesc Med 1984;138:479-482.
ABSTRACT  

Vasculitis, Pulmonary Cavitation, and Anemia During Antithyroid Drug Therapy
Cassorla et al.
Arch Pediatr Adolesc Med 1983;137:118-122.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1981 American Medical Association. All Rights Reserved.